Development and Preclinical Evaluation of a Lyophilized Vaccine Against Equine Herpesvirus Type 4 (EHV-4)

Development and Preclinical Evaluation of a Lyophilized Vaccine Against Equine Herpesvirus Type 4 (EHV-4)

Background/Objectives: Equine rhinopneumonia, caused by equine herpesvirus types 1 and 4 (EHV-1 and EHV-4), continues to be a significant health and economic concern in the global equine industry, particularly in Kazakhstan. While vaccines targeting EHV-1 are available, there is currently no license...

Full description

Saved in:
Bibliographic Details
Main Authors: Lespek Kutumbetov, Balzhan Myrzakhmetova, Aiganym Tussipova, Gulzhan Zhapparova, Talshyn Tlenchiyeva, Karina Bissenbayeva, Sergazy Nurabayev, Aslan Kerimbayev
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Vaccines
Subjects:
equine herpesvirus type 4
lyophilized vaccine
EHV-4 vaccine
thermostability
immunogenicity
vaccine development
Online Access:https://www.mdpi.com/2076-393X/13/6/604
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2076-393X/13/6/604

Similar Items